Table 4.
ID | Best BLAST hit | # unique peptides | % coverage |
---|---|---|---|
Contig14a | CRISP | 42 | 51.90% |
Contig29b | CRISP | 5 | 6.87% |
LHV_229_Sp6 | CRISP | 5 | 24.30% |
LHV_312_Sp6 | CRISP | 2 | 3.77% |
Contig12556 | CRISP | 21 | 38.90% |
Contig7836 | CRISP | 25 | 44.30% |
venom_comp104578_c0_seq1 | ICK | 2 | 27.00% |
HV209_Sp6_4 | α-latrotoxin | 2 | 11.60% |
gi|380876959|sp|P0DJE7.1|LITD_LATHE | δ-latroinsectotoxin | 3 | 17.00% |
Contig2826 | α-latroinsectotoxin | 47 | 35.40% |
Contig9724 | α-latrotoxin | 23 | 23.50% |
Contig9749 | α-latrotoxin | 43 | 40.30% |
Venom_comp106397_c0_seq1 | δ-latroinsectotoxin | 32 | 30.50% |
Venom_comp107842_c0_seq1 | δ-latroinsectotoxin | 15 | 30.00% |
Venom_comp107842_c2_seq1 | δ-latroinsectotoxin | 3 | 37.70% |
Venom_comp109612_c1_seq1 | δ-latroinsectotoxin | 4 | 19.30% |
Venom_comp110241_c0_seq1 | α-latrotoxin | 7 | 8.98% |
Venom_comp110271_c0_seq3 | α-latrotoxin | 2 | 6.88% |
Venom_comp110271_c1_seq1 | α-latrotoxin | 28 | 28.00% |
Venom_comp110278_c1_seq1 | α-latrotoxin | 25 | 26.60% |
Venom_comp110315_c0_seq1 | α-latrotoxin | 8 | 25.80% |
Venom_comp110315_c1_seq1 | α-latrotoxin | 14 | 20.20% |
Venom_comp110343_c2_seq1 | δ-latroinsectotoxin | 3 | 5.50% |
Venom_Contig10080 | δ-latroinsectotoxin | 8 | 8.76% |
Venom_Contig10081 | δ-latroinsectotoxin | 4 | 4.40% |
Venom_Contig10082 | δ-latroinsectotoxin | 4 | 4.42% |
Venom_Contig10158 | δ-latroinsectotoxin | 6 | 13.30% |
Venom_Contig11531 | α-latrocrustotoxin | 44 | 35.90% |
aContains EST sequences LHV_167_Sp6, LHV_012_T7, LHV_012_Sp6, LHV_194_Sp6, LHV_167_T7.
bContains EST sequences LHV_250_Sp6, LHV_144_Sp6, LHV_069_Sp6, LHV_069_T7, LHV_511_Sp6, LHV_123_T7, LHV_123_Sp6, LHV_144_T7, LHV_457_Sp6.
The type of toxin identified by the top BLAST hit to each transcript is shown in column 2. Proteomic evidence is displayed in columns 3 (unique peptides mapping to sequence) and 4 (% coverage of predicted protein with mapped peptides).